The broad AI boom is giving way to targeted applications in warehouse robotics, cybersecurity and domain- specific models, creating opportunities for funds like the ALPS Disruptive Technologies ETF (DTEC), according to Gartner's latest technology forecast. Gartner's Top 10 Strategic Technology Trends for 2026 report shows enterprises moving away from general-purpose AI tools toward specialized applications in three key areas: robotics, security and industry- specific AI models. DTEC holds exposure across al ...

December 11, 2025 05:19 AM GMT Beijing Geekplus Technology Co., Ltd. | Asia Pacific Warehouse Visit Takeaways: How AMRs Are Enhancing Efficiency Efficiency gains and cost savings through AMR solution: We visited the YesAsia (2209.HK, not covered) warehouse in Tsing Yi, Hong Kong, where the 140k sqft facility has deployed 161 Geekplus autonomous mobile robots (AMRs, all are shelf- to-person solution). Key highlights include: Geekplus's management said US market order growth accelerated to ~60% YoY YTD vs. ov ...

Mark Delaney from Goldman Sachs set a price target of $47 for SYM, which is approximately -44.9% from its current price.Symbotic's stock has risen by 4.04%, indicating investor optimism despite the significant price difference from the target.The company's market capitalization is approximately $51.51 billion, reflecting a strong market presence and active investor interest in the robotics technology sector.Symbotic Inc., trading on NASDAQ:SYM, is a company that focuses on automating warehouse operations th ...

| SYM Symbotic | | | | --- | --- | --- | | 5 460 + +1.820 +3.39% | | 收盘价 11/24 16:00 美东 | | 63.120↑ 7.660 +13.81% | | 盘前价 11/25 04:10 美东 | | 三 24 4 5 8 8 日 ♥自选 | | ● 快捷交易 | | 最高价 56.045 | 开盘价 55.810 | 成交量 408.51万 | | 最低价 51.862 | 昨收价 53.640 | 成交额 2.26亿 | | 平均价 55.391 | 市福率 IM 写损 | 总市值 63.01亿 (-) | | 振 幅 7.80% | 市盈率(静) 亏损 | 总股本 1.14亿 | | 换手率 4.71% | 市净率 28.470 | 流通值 48.12亿 | | 52周最高 84.000 | 委 比 -97.49% | 流通股 8676.82万 | | 52周最低 16.318 | 量 比 1.89 | 每 手 1股 | | 历史最高 84.000 | 股息TTM -- | | | 历史最低 8.750 | 股息率ITM - ...

Core Insights - Investors are exploring beyond major AI players like Nvidia and Palantir, with Symbotic emerging as a strong contender for future growth [1][3] - Symbotic's stock has surged 134% in 2025, outperforming Nvidia's 36% and Palantir's 114% gains [3] Company Performance - Symbotic reported a 9% increase in revenue to $618 million for fiscal Q4 2025, exceeding both management's and analysts' expectations [7] - Adjusted EBITDA rose 17% to $49 million, with operating cash flow and free cash flow reported at $530 million and $494 million, respectively [7] - The company has a substantial contractual backlog of $22.5 billion, indicating strong future growth potential [8] Future Outlook - Symbotic forecasts Q1 fiscal 2026 revenue of $620 million and EBITDA of $51 million, surpassing Wall Street's expectations of $612 million [8] - The company launched 10 new system deployments in Q4, bringing the total to 48, nearly doubling from fiscal 2024 [9] - Analysts expect continued gross margin expansion due to effective cost management and strong supply chain partnerships [9] Market Position - Symbotic's stock is currently valued at less than 3 times sales, with an anticipated annual revenue growth of 24% over the next five years [12] - Oppenheimer analyst Colin Rusch has set a price target of $83 for Symbotic, suggesting a potential upside of 50% from its recent closing price [11]

Financial Data and Key Metrics Changes - For the full fiscal year 2025, the company reported a revenue increase of 26% year over year, with fourth-quarter revenue growing 10% year over year to $618 million [4][10] - The net loss for the fourth quarter was $19 million, compared to a net income of $16 million in the same quarter of fiscal year 2024 [10] - Adjusted EBITDA for the fourth quarter was $49 million, up from $42 million in the fourth quarter of fiscal year 2024 [10] - Cash on the balance sheet exceeded $1.2 billion, up from $778 million in the fiscal third quarter [13] Business Line Data and Key Metrics Changes - Software revenue grew 57% year over year to $9.3 million in the fourth quarter, while operation services revenue increased 21% year over year to $26.9 million [12] - The backlog remained strong at $22.5 billion, with an increase from $22.4 billion in the previous quarter [10][11] Market Data and Key Metrics Changes - The company signed a new customer, Medline, marking its entry into the healthcare vertical, which has significant potential due to the large number of healthcare distribution centers in the U.S. [8] - The company is expanding its reach with GreenBox, signing new sites in Dallas and Chicago, extending coverage from California to the Midwest and Southeast [7][8] Company Strategy and Development Direction - The company aims to harness its growing product portfolio to broaden opportunities, particularly in e-commerce with its micro-fulfillment solution [9] - Key objectives for fiscal year 2026 include unlocking higher margins and continuing investment in innovation to support future growth [9] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growing sales pipeline and the ability to deliver higher value through innovative technology and improved installation efficiency [6][9] - The introduction of next-generation storage technology is expected to impact revenue phasing throughout fiscal year 2026, with less pronounced growth in the first half and a ramp-up in the second half [14][20] Other Important Information - The company is focused on improving operational efficiencies and reducing installation times, which are expected to generate significant savings for customers [6][7] - Management highlighted the importance of attracting and retaining talent, with strategic investments in R&D to support the expanding product portfolio [13][48] Q&A Session Summary Question: Can you provide more color on the Medline relationship and its potential? - Management indicated that the relationship with Medline was developed over a year, focusing on the unique capabilities of their system to meet healthcare needs [17] Question: What is the expectation for ramping next-gen systems? - Management confirmed that the ramp-up for next-gen systems is expected to occur in the second half of fiscal 2026, with stable revenue in the first half [20] Question: Can you discuss the specifics of the Medline project? - The initial engagement with Medline is a proof of concept at one site, with potential for future expansion based on performance [23] Question: How is the company addressing the backlog and new customer opportunities? - Management emphasized that while they do not guide on backlog, they are optimistic about new customer acquisitions and the potential for growth in 2026 [34] Question: What are the implications of the new battery technology partnership? - The partnership with Nyobolt is expected to enhance the reliability of bots, particularly in regions with erratic power supply [70] Question: How does the company view its expansion into Europe? - Management is optimistic about opportunities in Europe, with half of the sales team already engaged there [73]

Financial Data and Key Metrics Changes - For the full fiscal year 2025, revenue increased by 26% year over year, with fourth quarter revenue growing 10% year over year to $618 million, exceeding expectations [4][10] - The net loss for the fourth quarter was $19 million compared to a net income of $16 million in the same quarter of fiscal year 2024 [10] - Adjusted EBITDA for the fourth quarter was $49 million, up from $42 million in the fourth quarter of fiscal year 2024 [10][12] - Cash on the balance sheet exceeded $1.2 billion, up from $778 million in the fiscal third quarter [10][13] Business Line Data and Key Metrics Changes - Software revenue grew 57% year over year to $9.3 million in the fourth quarter, while operation services revenue increased by 21% year over year to $26.9 million [12] - The backlog remained strong at $22.5 billion, with an increase from $22.4 billion last quarter due to final pricing on projects and the addition of backlog associated with Medline [10][11] Market Data and Key Metrics Changes - The company signed a new customer, Medline, marking its entry into the healthcare vertical, which has significant potential with over 500 healthcare distribution centers in the U.S. [7][8] - The company is expanding its reach with GreenBox, signing new sites near Dallas and Chicago, extending coverage from California to the Midwest and Southeast [6][8] Company Strategy and Development Direction - The company aims to harness its growing product portfolio to broaden opportunities, particularly in e-commerce with micro-fulfillment solutions [9] - Key objectives for fiscal year 2026 include unlocking higher margins through operational improvements and continued investment in innovation [9] - The introduction of next-generation storage structures is expected to enhance deployment efficiency and customer value, contributing to higher margins over time [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational improvements and the ability to handle a broader customer base, indicating a bullish outlook for future growth [19] - The company anticipates less pronounced sequential revenue growth in the first half of fiscal 2026, with a ramp-up expected in the second half [21][66] - Management highlighted the importance of technology advancements and competitive differentiation in driving customer interest and market opportunities [16][86] Other Important Information - The company is focusing on geographic expansion, with half of its sales team currently in Europe, indicating optimism about opportunities in that market [63] - The partnership with Nyobolt for battery technology is expected to enhance the reliability of bots, addressing challenges related to power fluctuations [59][61] Q&A Session Summary Question: Can you provide more details on the Medline relationship and its potential? - The Medline relationship was developed over a year, focusing on the system's ability to handle numerous items with accuracy and speed, which is critical for healthcare [18] Question: What is the expectation for ramping next-gen systems? - The expectation is for a stable revenue in the first half of fiscal 2026, with a significant increase anticipated in the second half [20][21] Question: Can you elaborate on the Medline project specifics? - The initial engagement with Medline is a proof of concept at one site, with potential for upselling additional services in the future [23] Question: How is the company addressing the competitive landscape? - The company believes its technology offers unique capabilities that can augment existing systems, presenting significant opportunities for expansion with Medline [80] Question: What are the implications of the recent changes in the retail sector? - The changes in the retail sector have increased interest in the company's technology, particularly in addressing e-commerce challenges [85]

WILMINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its fourth fiscal quarter and fiscal year 2025, which ended on September 27, 2025. Symbotic reported revenue of $618 million, a net loss of $19 million and adjusted EBITDA1 of $49 million for the fourth quarter of fiscal year 2025. In comparison, Symbotic posted revenue of $565 million, net income of $16 million and adjusted EBIT ...

Key Takeaways Symbotic is set to report Q4 results with consensus calling for modest revenue and earnings growth.SYM's sizable backlog and planned conversion are expected to support its fiscal Q4 revenue range.Symbotic's shares have surged, but its high forward price-to-sales ratio underscores valuation pressure.Symbotic Inc. (SYM) will report fourth-quarter fiscal 2025 (ended Sept. 30, 2025) results on Nov. 24, after market close.The Zacks Consensus Estimate for revenues in the to-be-reported quarter is pe ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Zhongding Intelligent (Wuxi) Technology Co., Ltd. (中鼎智能（無錫）科技股份有限公司 ) (the "Company") (A joint stock company incorp ...